We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Whitepapers
Zeno Trap: Defining New Levels of Sensitivity
Whitepaper

Zeno Trap: Defining New Levels of Sensitivity

Download this whitepaper to discover a system that enhances sensitivity and maintains high resolution, fast scan speed as well as a wide dynamic range.
Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies
Whitepaper

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy, and combination immunotherapies increase cost of treatment and heighten the risk for toxicity-related adverse events.
Accelerating Cancer Immune Cell Therapies
Whitepaper

Accelerating Cancer Immune Cell Therapies

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life.
Challenging Host Cell Protein Assays for Improved Risk Mitigation
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

Host Cell Proteins (HCPs) are a heterogeneous, complex group of proteins that derived from the host cell. Regulatory agencies examine each protein drug on a case-by-case basis to determine appropriate maximum acceptable levels of HCPs considering patient risk.
Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies
Whitepaper

Protein Biomarkers Show Promise in Predicting Patient Response to Cancer Immunotherapies

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy.
Advancing the Development of Therapeutics Against Infectious Diseases
Whitepaper

Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Calibration Certificates From Accredited Providers
Whitepaper

Calibration Certificates From Accredited Providers

Download this whitepaper to learn about the advantages of calibration certificates, concepts of accredited calibration and traceability of test equipment.
Reliable Results from Cell-Based Bioassays
Whitepaper

Reliable Results from Cell-Based Bioassays

While common laboratory plastics are generally regarded as inert by researchers, some commonly used products such as pipette tips and sample tubes have been reported to leach chemical compounds including oleamide, erucamide and DiHEMDA.
Profiling Host Responses in COVID-19 Infections
Whitepaper

Profiling Host Responses in COVID-19 Infections

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.
Quantify and Characterize Host Cell Protein With Confidence
Whitepaper

Quantify and Characterize Host Cell Protein With Confidence

Download this whitepaper to learn more about how dilutional linearity enhances reliability, undetected HCP can be minimized as well as consistently low variation ensures reproducible data.
Advertisement